Truist Financial’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-455,300
Closed -$1.07M 2818
2025
Q4
$1.07M Sell
455,300
-64,500
-12% -$176K ﹤0.01% 1626
2025
Q3
$1.59M Buy
519,800
+232,900
+81% +$665K ﹤0.01% 1451
2025
Q2
$800K Buy
286,900
+71,200
+33% +$234K ﹤0.01% 1713
2025
Q1
$774K Sell
215,700
-7,900
-4% -$31.7K ﹤0.01% 1645
2024
Q4
$704K Buy
223,600
+98,100
+78% +$351K ﹤0.01% 1712
2024
Q3
$354K Buy
+125,500
New +$287K ﹤0.01% 2042

Other funds holding CLOV

Truist Financial's CLOV Position: Q1 2026 in Review

Truist Financial reduced its Clover Health Investments (CLOV) stake by 14% in Q1 2026, selling an estimated $4.34K and leaving 12,125 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

Truist Financial first reported a position in CLOV in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.05M in Q2 2021. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Truist Financial held 12,125 shares of Clover Health Investments worth $21.3K as of Q1 2026.
  • Truist Financial sold 2,000 Clover Health Investments shares in Q1 2026, an estimated $4.34K.
  • Clover Health Investments made up ﹤0.01% of Truist Financial's portfolio in Q1 2026, its #2774 holding.
  • Truist Financial first reported a position in Clover Health Investments in Q1 2021 and has held it in 21 quarters since.
  • Truist Financial's Clover Health Investments position peaked at $1.05M in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.